You are here

Board of Overseers

Board of Overseers members help the Science History Institute reach others who understand and appreciate the impact of chemistry, chemical engineering, and the life sciences on society.

Daniel Adams
Protein Sciences Corporation

Fred Aftalion
Fondation de la Maison de la Chimie

Ivan Amato
Author

Paul S. Anderson
Merck & Company, retired

John J. Baldwin
Vitae Pharmaceuticals

Sol Barer
Celgene

Jacqueline K. Barton
California Institute of Technology

Rudy M. Baum
Chemical and Engineering News

James Blair
Domain Associates

Joshua Boger
Vertex Pharmaceuticals

Brook Byers
Kleiner Perkins Caufield & Byers

Ronald C. D. Breslow
Columbia University

Mark J. Cardillo
Camille and Henry Dreyfus Foundation

Robert Carpenter
Hydra Biosciences

Marc Casper
Thermo Fisher Scientific

Nancy Chang
Apex Enterprise Inc.

Pat N. Confalone
Confalone Consulting, LLC

Susan Desmond-Hellmann
Bill & Melinda Gates Foundation

Roy T. Eddleman
Spectrum Laboratories

Lawrence B. Evans
Cofounder, Rive Technology

Robert E. Finnigan
Finnigan Corporation

Jay Flatley
Illumina

Marye Anne Fox
University of California, San Diego

Frederick Frank
Evolution Life Science Partners

Chris Garabedian
Xontogeny

James M. Gentile
Research Corporation

Dennis Gillings
GHO Capital

Alan Gold
BioMed Realty

Joseph Goldstein
UT Southwestern Medical Center

Robert W. Gore
W. L. Gore and Associates

Harry B. Gray
Beckman Institute, California Institute of Technology

James Greenwood
Biotechnology Innovation Organization

Robert H. Grubbs
California Institute of Technology

Harry Gruber
Tocagen

Rajiv L. Gupta
Avantor Performance Materials

David W. Haas
The William Penn Foundation

Bruce J. Hach
Hach Scientific Foundation

David Hale
Hale BioPharma Ventures

William Haseltine
ACCESS Health International

Paul Hastings
OncoMed Pharmaceuticals

Dudley R. Herschbach
Harvard University

Roald Hoffmann
Cornell University

Sally Smith Hughes
University of California, Berkeley

Perry Karsen
Celgene

Rachel K. King
GlycoMimetics, Inc.

Art Levinson
Calico Labs

Thomas B. Lewis
Chiral Technologies, retired

Greg Lucier
NuVasive

Maria Maccecchini
QR Pharma Inc.

Magda Marquet
Ajinomoto Althea

Catherine C. Maxey
Trinseo LLC

Carver A. Mead
California Institute of Technology

David Meeker
Sanofi Genzyme

Alan Mendelson
Latham & Watkins

Fred Middleton
Sanderling Ventures

Joseph A. Miller, Jr.
Corning Corporation, retired

Gordon E. Moore
Intel Corporation

Scott Morrison
Ernst & Young, retired

Tina Nova
Molecular Stethoscope

Mary Jo Nye
Oregon State University

Michael H. Ott
Polysciences, Inc.

Stelios Papadopoulos
Biogen

Rudolph Pariser
DuPont

Adelene Perkins
Infinity Pharmaceuticals

Cecil B. Pickett
Zimmer Holdings, Inc.

Richard Pops
Alkermes

George Poste
Arizona State University

Dennis Purcell
Aisling Capital

Edward Richman
Richman Chemical Inc.

Roberto Rosenkranz
Roxro Pharma

Ivor Royston
Viracta Therapeutics

William Rutter
Synergenics

George Scangos
Biogen

Phillip A. Sharp
Massachusetts Institute of Technology

Jay Siegel
Janssen Research & Development

Vince Simmon
Genex

Mark Skaletsky
Fenway Pharmaceuticals

Harold A. Sorgenti
Sorgenti Investment Partners

Peter H. Spitz
Chem Systems

A. Wayne Tamarelli
AWT Private Investments

Holden H. Thorp
Washington University

Thomas Turi
Covance

J. Craig Venter
J. Craig Venter Institute

Josef von Rickenbach
PAREXEL International Corporation

Richard N. Zare
Stanford University